FSMAX
Price
$94.93
Change
-$0.10 (-0.11%)
Updated
Aug 5 closing price
Net Assets
39.63B
OTCHX
Price
$30.58
Change
-$0.16 (-0.52%)
Updated
Aug 5 closing price
Net Assets
15.2B
Interact to see
Advertisement

FSMAX vs OTCHX

Header iconFSMAX vs OTCHX Comparison
Open Charts FSMAX vs OTCHXBanner chart's image
Fidelity Extended Market Index
Price$94.93
Change-$0.10 (-0.11%)
VolumeN/A
Net Assets39.63B
MFS Mid Cap Growth R3
Price$30.58
Change-$0.16 (-0.52%)
VolumeN/A
Net Assets15.2B
FSMAX vs OTCHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. OTCHX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and OTCHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. OTCHX (15.2B). FSMAX pays higher dividends than OTCHX: FSMAX (0.46) vs OTCHX (0.00). FSMAX was incepted earlier than OTCHX: FSMAX (14 years) vs OTCHX (20 years). OTCHX (1.04) is less costly to investors than FSMAX (0.04). OTCHX is a more actively managed with annual turnover of: 35.00 vs. FSMAX (9.00). FSMAX (0) and OTCHX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 21.86 vs. OTCHX (13.43). FSMAX return over 5 years is better than : 52.00 vs. OTCHX (26.92).
FSMAXOTCHXFSMAX / OTCHX
Total Expense Ratio0.041.033%
Annual Report Gross Expense Ratio0.041.043%
Fund Existence14 years20 years-
Gain YTD4.5668.77652%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B15.2B261%
Annual Yield % from dividends0.460.00-
Returns for 1 year21.8613.43163%
Returns for 3 years38.8428.40137%
Returns for 5 years52.0026.92193%
Returns for 10 years84.21105.3480%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE13.130.46
+3.63%
Lands' End
HALO60.810.82
+1.37%
Halozyme Therapeutics
CHSCP28.590.07
+0.23%
CHS
ICCC6.18-0.06
-0.96%
ImmuCell Corp
SRPT16.75-0.35
-2.05%
Sarepta Therapeutics